(Q35073990)

6 August 2017

1 reference

title

Adenosine in myocardial protection in on-pump and off-pump cardiac surgery (English)

1 reference

6 August 2017

0 references

6

Vinod H Thourani

1 reference

6 August 2017

author name string

Jakob Vinten-Johansen

1

1 reference

6 August 2017

Zhi-Qing Zhao

2

1 reference

6 August 2017

Joel S Corvera

3

1 reference

6 August 2017

Cullen D Morris

4

1 reference

6 August 2017

Jason M Budde

5

1 reference

6 August 2017

Robert A Guyton

7

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

The Annals of Thoracic Surgery

6 August 2017

published in

1 reference

6 August 2017

volume

75

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

S691-9

1 reference

The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Species-dependent effects of adenosine on heart rate and atrioventricular nodal conduction. Mechanism and physiological implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Adenosine: a physiological modulator of superoxide anion generation by human neutrophils.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Cardioprotection by adenosine: is it a question of effective dose, timing, or the target compartment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs. Efficacy, time course, and role of KATP channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Adenosine A1 receptor mediated protection of the globally ischemic isolated rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Salutary effects of exogenous adenosine administration on in vivo myocardial stunning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Adenosine A1 receptor activation reduces reactive oxygen species and attenuates stunning in ventricular myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Protection from ischaemic-reperfusion injury with adenosine pretreatment is reversed by inhibition of ATP sensitive potassium channels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Neutrophil and endothelial changes in reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Neutrophil accumulation in ischemic canine myocardium. Insights into time course, distribution, and mechanism of localization during early reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

The role of the neutrophil and free radicals in ischemic myocardial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Neutrophils as potential participants in acute myocardial ischemia: relevance to reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

A novel adenosine analog, AMP579, inhibits neutrophil activation, adherence and neutrophil-mediated injury to coronary vascular endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury during 24 h of reperfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Ischemic preconditioning in cardiac surgery: a word of caution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Adenosine-enhanced ischemic preconditioning provides enhanced postischemic recovery and limitation of infarct size in the rabbit heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Adenosine-enhanced ischemic preconditioning: adenosine receptor involvement during ischemia and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Adenosine-enhanced ischemic preconditioning provides enhanced cardioprotection in the aged heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Adenosine-enhanced ischemic preconditioning modulates necrosis and apoptosis: effects of stunning and ischemia-reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Preconditioning of human myocardium with adenosine during coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Intracoronary administration of dipyridamole prior to percutaneous transluminal coronary angioplasty provides a protective effect exceeding that of ischemic preconditioning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Intravenous adenosine and lidocaine in patients with acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Pretreatment of human myocardium with adenosine during open heart surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Cardioprotective effect of adenosine pretreatment in coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Is adenosine preconditioning truly cardioprotective in coronary artery bypass surgery?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Cellular protection during myocardial ischemia: the development and characterization of a procedure for the induction of reversible ischemic arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Adenosine in blood cardioplegia prevents postischemic dysfunction in ischemically injured hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Safety, tolerance, and efficacy of adenosine as an additive to blood cardioplegia in humans during coronary artery bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Adenosine reduces postbypass transfusion requirements in humans after heart surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Optimal Myocardial Preconditioning in Humansa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Perfusion-assisted direct coronary artery bypass: selective graft perfusion in off-pump cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Experimental off-pump coronary artery revascularization with adenosine-enhanced reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

Anti-stunning and anti-infarct effects of adenosine-enhanced ischemic preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904694-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0003-4975(02)04694-5

1 reference

6 August 2017

1 reference